Webinar | December 12, 2025

Hear From The Experts: LNPs Driving The Future Of Cell Therapy

Source: Cytiva

Lipid nanoparticles (LNPs) are transforming cell therapy by enabling precise, scalable delivery of genetic tools. From transient mRNA expression to genome editing, LNPs offer new opportunities for engineering immune cells and advancing next-generation therapies. In this webinar, Dr. Sandy Tretbar (Fraunhofer IZI) explores mRNA-LNP technologies that enhance safety, precision, and manufacturing flexibility in immune cell engineering. Dr. Friederike Herbst-Nowrouzi (University of Pennsylvania) introduces a groundbreaking two-component immunotherapy platform using base-edited CAR T cells and CD34⁺ HSPCs, powered by LNP-mediated delivery of genome editing tools.

Discover how these innovations are accelerating the path from research to clinical translation.

access the Webinar!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

Cytiva